DAX24.330 +0,3%Est505.687 +0,1%MSCI World4.343 -0,1%Top 10 Crypto15,21 -2,6%Nas22.977 -0,1%Bitcoin96.671 +1,7%Euro1,1603 -0,4%Öl61,35 +0,7%Gold4.114 -5,6%
Beliebte Suche
DAX 40 Ölpreis Euro - Dollar Bitcoin - Euro Goldpreis
Meistgesucht
TKMS thyssenkrupp Marine Systems TKMS00 Rheinmetall 703000 Beyond Meat A2N7XQ DroneShield A2DMAA NVIDIA 918422 RENK RENK73 thyssenkrupp 750000 Infineon 623100 Tesla A1CX3T Novo Nordisk A3EU6F Apple 865985 HENSOLDT HAG000 Amazon 906866 Plug Power A1JA81 Deutsche Telekom 555750
Alle Aktien für 0 Euro (zzgl. Spreads) handeln mit finanzen.net zero. Hier informieren
Heute im Fokus
Trump setzt auf Handelsdeal: DAX schließt nach Richtungssuche im Plus -- Netflix vor Bilanz -- Meta, Gold, TKMS, Novo Nordisk, Infineon, Rüstungswerte, Beyond Meat im Fokus
Top News
Handelskonflikt und Tech-Giganten im Blick: DAX kann nach Richtungssuche etwas höher schließen Handelskonflikt und Tech-Giganten im Blick: DAX kann nach Richtungssuche etwas höher schließen
Stellar: So viel hätten Anleger mit einem Investment von vor 3 Jahren verdient Stellar: So viel hätten Anleger mit einem Investment von vor 3 Jahren verdient
Suche...
Login
ODER

Neu auf finanzen.net?

Kostenfrei registrieren und Vorteile nutzen

Übersicht Wertpapierdepots Musterdepots Watchlists Meine News Newsletter Forum Trading Desk Apps Social Media Podcasts
Profil
Wer­bung
Jetzt Gratis-Aktie sichern! Konto bei XTB eröffnen, Geld einzahlen, Aktie erhalten. Infos: aktien.xtb.com/gratis-aktie. Investments bergen Risiken.

EQS-PVR: BRAIN Biotech AG: Release according to Article 40, Section 1 of the WpHG [the German Securities Trading Act] with the objective of Europe-wide distribution

20.10.25 15:38 Uhr
Werte in diesem Artikel
Aktien
BRAIN Biotech AG
2,27 EUR -0,02 EUR -0,87%
Charts|News|Analysen
Aktie kaufen

EQS Voting Rights Announcement: BRAIN Biotech AG
BRAIN Biotech AG: Release according to Article 40, Section 1 of the WpHG [the German Securities Trading Act] with the objective of Europe-wide distribution

20.10.2025 / 15:38 CET/CEST
Dissemination of a Voting Rights Announcement transmitted by EQS News - a service of EQS Group.
The issuer is solely responsible for the content of this announcement.

Wer­bung

Notification of Major Holdings

1. Details of issuer
Name: BRAIN Biotech AG
Street: Darmstädter Straße 34-36
Postal code: 64673
City: Zwingenberg
Germany
Legal Entity Identifier (LEI): 391200JKPVHLD6JLZ107

2. Reason for notification
X Acquisition/disposal of shares with voting rights
  Acquisition/disposal of instruments
  Change of breakdown of voting rights
  Other reason:

3. Details of person subject to the notification obligation
Legal entity: Universal-Investment-Gesellschaft mit beschränkter Haftung
City of registered office, country: Frankfurt am Main, Germany

4. Names of shareholder(s)
holding directly 3% or more voting rights, if different from 3.
 

5. Date on which threshold was crossed or reached:
15 Oct 2025

6. Total positions
  % of voting rights attached to shares
(total of 7.a.)		 % of voting rights through instruments
(total of 7.b.1 + 7.b.2)		 Total of both in %
(7.a. + 7.b.)		 Total number of voting rights pursuant to Sec. 41 WpHG
New 2.99 % 0.00 % 2.99 % 21847495
Previous notification 4.99 % 0.00 % 4.99 % /

7. Details on total positions
a. Voting rights attached to shares (Sec. 33, 34 WpHG)
ISIN Absolute In %
  Direct
(Sec. 33 WpHG)		 Indirect
(Sec. 34 WpHG)		 Direct
(Sec. 33 WpHG)		 Indirect
(Sec. 34 WpHG)
DE0005203947 0 652894 0.00 % 2.99 %
Total 652894 2.99 %

b.1. Instruments according to Sec. 38 (1) no. 1 WpHG
Type of instrument Expiration or maturity date Exercise or conversion period Voting rights absolute Voting rights in %
0 0.00 %
    Total 0 0.00 %

b.2. Instruments according to Sec. 38 (1) no. 2 WpHG
Type of instrument Expiration or maturity date Exercise or conversion period Cash or physical settlement Voting rights absolute Voting rights in %
0 0.00 %
      Total 0 0.00 %

8. Information in relation to the person subject to the notification obligation
  Person subject to the notification obligation is not controlled nor does it control any other undertaking(s) that directly or indirectly hold(s) an interest in the (underlying) issuer (1.).
X Full chain of controlled undertakings starting with the ultimate controlling natural person or legal entity:

Name % of voting rights (if at least 3% or more) % of voting rights through instruments (if at least 5% or more) Total of both (if at least 5% or more)
-Universal-Investment-Gesellschaft mit beschränkter Haftung % % %
-Universal-Investment-Luxembourg S.A. % % %

9. In case of proxy voting according to Sec. 34 para. 3 WpHG
(only in case of attribution of voting rights in accordance with Sec. 34 para. 1 sent. 1 No. 6 WpHG)

Date of general meeting:
Holding total positions after general meeting (6.) after annual general meeting:
Proportion of voting rights Proportion of instruments Total of both
% % %

10. Other explanatory remarks:
 

Date
17 Oct 2025


20.10.2025 CET/CEST The EQS Distribution Services include Regulatory Announcements, Financial/Corporate News and Press Releases.
View original content: EQS News

Language: English
Company: BRAIN Biotech AG
Darmstädter Straße 34-36
64673 Zwingenberg
Germany
Internet: www.brain-biotech.com

 
End of News EQS News Service
Wer­bung

2215672  20.10.2025 CET/CEST

Ausgewählte Hebelprodukte auf BRAIN Biotech

Mit Knock-outs können spekulative Anleger überproportional an Kursbewegungen partizipieren. Wählen Sie einfach den gewünschten Hebel und wir zeigen Ihnen passende Open-End Produkte auf BRAIN Biotech

NameHebelKOEmittent
NameHebelKOEmittent
Wer­bung

Nachrichten zu BRAIN Biotech AG

DatumMeistgelesen
Wer­bung